Next Article in Journal
Formulation of Sustained Release Hydrophilic Matrix Tablets of Tolcapone with the Application of Sedem Diagram: Influence of Tolcapone’s Particle Size on Sustained Release
Next Article in Special Issue
Prediction of Drug-Induced Hyperbilirubinemia by In Vitro Testing
Previous Article in Journal
Food Effects on Oral Drug Absorption: Application of Physiologically-Based Pharmacokinetic Modeling as a Predictive Tool
Previous Article in Special Issue
Validation of Pharmacological Protocols for Targeted Inhibition of Canalicular MRP2 Activity in Hepatocytes Using [99mTc]mebrofenin Imaging in Rats
Article

IPEC-J2 rMdr1a, a New Cell Line with Functional Expression of Rat P-glycoprotein Encoded by Rat Mdr1a for Drug Screening Purposes

1
Bioneer A/S, Kogle Alle 2, DK-2970 Hørsholm, Denmark
2
Department of Pharmacy, University of Copenhagen, Universitetsparken 2, DK-2100 Copenhagen, Denmark
*
Author to whom correspondence should be addressed.
Pharmaceutics 2020, 12(7), 673; https://doi.org/10.3390/pharmaceutics12070673
Received: 29 May 2020 / Revised: 14 July 2020 / Accepted: 15 July 2020 / Published: 17 July 2020
(This article belongs to the Special Issue Drug Transporters in Absorption, Disposition and Elimination)
The efflux pump P-glycoprotein (P-gp) affects drug distribution after absorption in humans and animals. P-gp is encoded by the multidrug resistance gene (MDR1) gene in humans, while rodents (the most common preclinical animal model) express the two isoforms Mdr1a and Mdr1b. Differences in substrate selectivity has also been reported. Our aim was to generate an in vitro cell model with tight barrier properties, expressing functional rat Mdr1a P-gp, as an in vitro tool for investigating species differences. The IPEC-J2 cell line forms extremely tight monolayers and was transfected with a plasmid carrying the rat Mdr1a gene sequence. Expression and P-gp localization at the apical membrane was demonstrated with Western blots and immunocytochemistry. Function of P-gp was shown through digoxin transport experiments in the presence and absence of the P-gp inhibitor zosuquidar. Bidirectional transport experiments across monolayers of the IPEC-J2 rMDR1a cell line and the IPEC-J2 MDR1 cell line, expressing human P-gp, showed comparable magnitude of transport in both the absorptive and efflux direction. We conclude that the newly established IPEC-J2 rMdr1a cell line, in combination with our previously established cell line IPEC-J2 MDR1, has the potential to be a strong in vitro tool to compare P-gp substrate profiles of rat and human P-gp. View Full-Text
Keywords: P-glycoprotein (ABCB1); P-gp substrates; efflux transport; in vitro model; species differences; drug delivery; drug disposition; drug screening P-glycoprotein (ABCB1); P-gp substrates; efflux transport; in vitro model; species differences; drug delivery; drug disposition; drug screening
Show Figures

Graphical abstract

MDPI and ACS Style

Saaby, L.; Trasborg, J.; Rasmussen, M.A.; Holst, B.; Brodin, B. IPEC-J2 rMdr1a, a New Cell Line with Functional Expression of Rat P-glycoprotein Encoded by Rat Mdr1a for Drug Screening Purposes. Pharmaceutics 2020, 12, 673. https://doi.org/10.3390/pharmaceutics12070673

AMA Style

Saaby L, Trasborg J, Rasmussen MA, Holst B, Brodin B. IPEC-J2 rMdr1a, a New Cell Line with Functional Expression of Rat P-glycoprotein Encoded by Rat Mdr1a for Drug Screening Purposes. Pharmaceutics. 2020; 12(7):673. https://doi.org/10.3390/pharmaceutics12070673

Chicago/Turabian Style

Saaby, Lasse, Josefine Trasborg, Mikkel A. Rasmussen, Bjørn Holst, and Birger Brodin. 2020. "IPEC-J2 rMdr1a, a New Cell Line with Functional Expression of Rat P-glycoprotein Encoded by Rat Mdr1a for Drug Screening Purposes" Pharmaceutics 12, no. 7: 673. https://doi.org/10.3390/pharmaceutics12070673

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop